Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS?

Mult Scler. 2024 Dec 7:13524585241303480. doi: 10.1177/13524585241303480. Online ahead of print.

Authors

Vittorio Viti¹, Chiara Zanetta^{1

2}, Maria A Rocca^{1

3

4}, Massimo Filippi^{1

2

3

4

5}

Affiliations

¹ Neurology Unit and Multiple Sclerosis Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.
² Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
³ Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁴ Vita-Salute San Raffaele University, Milan, Italy.
⁵ Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.

PMID: 39644144
DOI: 10.1177/13524585241303480

No abstract available